David A. Karanian
Pfizer (United States)(US)
Publications by Year
Research Areas
Neuroscience and Neuropharmacology Research, Cannabis and Cannabinoid Research, Neurotransmitter Receptor Influence on Behavior, Forensic Toxicology and Drug Analysis, Alzheimer's disease research and treatments
Most-Cited Works
- → Extinction-induced upregulation in AMPA receptors reduces cocaine-seeking behaviour(2003)321 cited
- → Effects of intranucleus accumbens shell administration of dopamine agonists and antagonists on cocaine-taking and cocaine-seeking behaviors in the rat(2005)150 cited
- → Dual Modulation of Endocannabinoid Transport and Fatty Acid Amide Hydrolase Protects against Excitotoxicity(2005)124 cited
- → Endocannabinoid Enhancement Protects against Kainic Acid-Induced Seizures and Associated Brain Damage(2007)92 cited
- → Quantitative Method for the Profiling of the Endocannabinoid Metabolome by LC-Atmospheric Pressure Chemical Ionization-MS(2007)86 cited
- → Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors(2016)76 cited
- → Microtubule-stabilizing agent prevents protein accumulation-induced loss of synaptic markers(2007)62 cited
- → Equipotent Inhibition of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase – Dual Targets of the Endocannabinoid System to Protect against Seizure Pathology(2012)59 cited
- → Targeting the endocannabinoid system in treating brain disorders(2006)55 cited
- → Extinction Training Regulates Tyrosine Hydroxylase during Withdrawal from Cocaine Self-Administration(2001)53 cited